A glycine site antagonist, ZD9379, reduces number of spreading depressions and infarct size in rats with permanent middle cerebral artery occlusion

Stroke

Volumn 29, Issue 1, 1998, Pages 190-195

  Tatlisumak, Turgut ^a,b   Takano, Kentaro ^a   Meiler, Michael R ^c   Fisher, Marc ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^b HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^c NONE

Author keywords

Cerebral ischemia; Middle cerebral artery occlusion; N methyl D aspartate; Rats; Spreading cortical depression

Indexed keywords

7 CHLORO 4 HYDROXY 2 (4 METHOXY 2 METHYLPHENYL) 1,2,5,10 TETRAHYDROPYRIDANIZO[4,5 B]QUINOLINE 1,10 DIONE; GLYCINE; GLYCINE RECEPTOR ANTAGONIST; N METHYL DEXTRO ASPARTIC ACID; TRIPHENYLTETRAZOLIUM; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN INFARCTION; BRAIN ISCHEMIA; COMMON CAROTID ARTERY; CONTROLLED STUDY; DRUG BINDING SITE; DRUG EFFECT; ELECTROCORTICOGRAPHY; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; MORTALITY; NEUROLOGIC EXAMINATION; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR BLOCKING; SCORING SYSTEM; SPREADING CORTICAL DEPRESSION;

EID: 0031974355     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.STR.29.1.190     Document Type: Article

References (38)

1. Leão AAP. Spreading depression of activity in the cerebral cortex. J Neurophysiol. 1944;7:359-390.
2. Marshall WH. Spreading cortical depression of Leão. Physiol Rev. 1959;39: 239-279.
3. Bureš J, Burešova O, Krivanek J. The Mechanism and Applications of Leão's Spreading Depression of Electroencephalographic Activity. New York, NY: Academic Press, Inc; 1974.
4. 14C]2-deoxyglucose phosphorylation. J Cereb Blood Flow Metab. 1986;6:607-615.
5. Marrannes R, Willems R, De-Prins E, Wauquier A. Evidence for a role of the N-methyl-D-aspartate (NMDA) receptor in cortical spreading depression in the rat. Brain Res. 1988;457:226-240.
6. Gill R, Andiné P, Hillered L, Persson L, Hagberg H. The effect of MK-801 on cortical spreading depression in the penumbral zone following focal ischaemia in the rat. J Cereb Blood Flow Metab. 1992;12:371-379.
7. Iijima T, Mies G, Hossmann K-A. Repeated negative DC deflections in rat cortex following middle cerebral artery occlusion are abolished by MK-801: effect on volume of ischemic injury. J Cereb Blood Flow Metab. 1992;12:727-733.
8. Chen Q, Chopp M, Bodzin G, Chen H. Temperature modulation of cerebral depolarization during focal cerebral ischemia in rats: correlation with ischemic injury. J Cereb Blood Flow Metab. 1993;13:389-394.
9. Nedergaard M, Hansen AJ. Characterization of cortical depolarizations evoked in focal cerebral ischemia. J Cereb Blood Flow Metab. 1993;13: 568-574.
10. Mies G, Iijima T, Hossmann K-A. Correlation between peri-infarct DC shifts and ischemic neuronal damage in rat. Neuroreport. 1993;4:709-711.
11. Back T, Kohno K, Hossmann K-A. Cortical negative DC deflections following middle cerebral artery occlusion and KCl-induced spreading depression: effect on cerebral blood flow, tissue oxygenation, and electroencephalogram. J Cereb Blood Flow Metab. 1994;14:12-19.
12. Back T, Ginsberg MD, Dietrich WD, Watson BD. Induction of spreading depression in the ischemic hemisphere following experimental middle cerebral artery occlusion: effect on infarct morphology. J Cereb Blood Flow Metab. 1996;16:202-213.
13. Takano K, Latour LL, Formato JE, Carano RAD, Helmer KG, Hasegawa Y, Sotak CH, Fisher M. The role of spreading depression in focal ischemia evaluated by diffusion mapping. Ann Neurol. 1996;39:308-318.
14. Hossmann K-A. Viability thresholds and the penumbra of focal ischemia. Ann Neurol. 1994;36:557-565.
15. Dietrich WD, Feng Z-C, Leistra H, Watson BD, Rosenthal M. Photothrombotic infarction triggers multiple episodes of cortical spreading depression in distant brain regions. J Cereb Blood Flow Metab. 1994;14:20-28.
16. Muir KW, Lees KR. Clinical experience with excitatory amino acid antagonist drugs. Stroke. 1995;26:503-513.
17. Kemp JA, Leeson PD. The glycine site of the NMDA receptor: five years on. Trends Pharmacol Sci. 1993;14:20-25.
18. Chen J, Graham SH, Moroni F, Simon RP. A study of the dose dependency of a glycine receptor antagonist in focal ischemia. J Pharmacol Exp Ther. 1993;267:937-941.
19. Warner DS, Martin H, Ludwig P, McAllister A, Keana JFW, Weber E. In vivo models of cerebral ischemia: effects of parenterally administered NMDA receptor glycine site antagonists. J Cereb Blood Flow Metab. 1995;15:188-196.
20. Gill R, Hargreaves RJ, Kemp JA. The neuroprotective effect of the glycine site antagonist 3R-(+)-cis-4-methyl-HA966 (L-687,414) in a rat model of focal ischaemia. J Cereb Blood Flow Metab. 1995;15:197-204.
21. Bare TM, Smith RW, Draper CW, Sparks RB, Pullan LM, Goldstein JM, Patel JB. Pyridanizo[4,5-b]quinolinediones: a series of novel glycine site NMDA antagonists with potent in vitro and in vivo properties. Abstracts of Papers of the American Chemical Society. 1993;205:79. Abstract.
22. Takano K, Tatlisumak T, Formato JE, Carano RAD, Bergmann AG, Pullan LM, Bare TM, Sotak CH, Fisher M. A glycine site antagonist, ZD9379, attenuates infarct size in experimental focal ischemia: postmortem and diffusion mapping studies. Stroke. 1997;28:1255-1263.
23. Van Harreveld A, and Fifková E. Glutamate release from the retina during spreading depression. J Neurobiol. 1970;2:13-29.
24. Koizumi J, Yoshida Y, Nakazawa T, Ooneda G. Experimental studies of ischemic brain edema, I: a new experimental model of cerebral embolism in rats in which recirculation can be introduced in the ischemic area. Jpn J Stroke. 1986;8:1-8.
25. Hasegawa Y, Fisher M, Latour LL, Dardzinski BJ, Sotak CH. MRI diffusion mapping of reversible and irreversible ischemic injury in focal brain ischemia. Neurology. 1994;44:1484-1490.
26. Reith W, Hasegawa Y, Latour LL, Dardzinski BJ, Sotak CH, Fisher M. Mukislice diffusion mapping for 3-D evolution of cerebral ischemia in a rat stroke model. Neurology. 1995;45:172-177.
27. Leeson PD, and Iverson LL. The glycine site on the NMDA receptor: structure-activity relationships and therapeutic potential. J Med Chem. 1994;24:117-121.
28. Zea Longa E, Weinstein PR, Carlson S, Cummins R. Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke. 1989;20:84-91.
29. Bederson JB, Pitts LH, Germano SM, Nishimura MC, Davis RL, Bartkowski HM. Evaluation of 2,3,5-triphenyltetrazolium chloride as a stain for detection and quantification of experimental cerebral infarction in rats. Stroke. 1986;17:1304-1308.
30. Lin T-N, He YY, Wu G, Khan M, Hsu CY. Effect of brain edema on infarct volume in a focal ischemia model in rats. Stroke. 1993;24:117-121.
31. Grafstein B. Mechanism of spreading cortical depression. J Neurophysiol. 1956;19:154-171.
32. Van Harreveld A. Compounds in brain extracts causing spreading depression of cerebral cortical activity and contraction of crustacean muscle. J Neurochem. 1959;3:300-315.
33. Mayer ML, MacDermott AB, Westbrook GI, Smith SJ, Barker JL. Agonist- and voltage-gated calcium entry in cultured mouse spinal cord neurons under voltage clamp measured using arsenazo III. J Neurosci. 1987;7:3230-3244.
34. Nellgård B, Wieloch T. NMDA-receptor but not NBQX, an AMPA-receptor antagonist, inhibit spreading depression in the rat brain. Acta Physiol Scand. 1992;146:497-503.
35. Johnson JW, Ascher P. Glycine potentiates the NMDA response in cultured mouse brain neurons. Nature. 1987;325:529-531.
36. Dalkara T, Erdemli G, Barun S, Onur R. Glycine is required for NMDA receptor activation: electrophysiological evidence from intact rat hippocampus. Brain Res. 1992;576:197-202.
37. Busto R, Globus MYT, Dietrich WD, Martinez E, Valdes I, Ginsberg MD. Effect of mild hypothermia on ischemia-induced release of neurotransmitters and free fatty acid in rat brain. Stroke. 1989;20(suppl VII):VII-904-VII-910.
38. Martin H, Warner DS, Todd MM. Effects of glycine receptor antagonism on spreading depression in the rat. Neurosci Lett. 1994;180:285-289.